Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2013; 19(12): 1861-1876
Published online Mar 28, 2013. doi: 10.3748/wjg.v19.i12.1861
Published online Mar 28, 2013. doi: 10.3748/wjg.v19.i12.1861
Figure 1 Proton pump inhibitors exacerbate naproxen-induced ulceration and bleeding.
In panel A, the top image is of the jejunum of a rat treated with naproxen for 4.5 d (10 mg/kg twice-daily). There are no ulcers present. The bottom image is of a jejunum of a rat receiving the same naproxen treatment, but also treated with omeprazole at a dose that suppressed gastric acid secretion[37]. The arrows indicate the numerous hemorrhagic ulcers that form with this combination of treatments; Panel B shows the change in hematocrit of rats treated with naproxen (Nap) plus vehicle (Veh), omeprazole (Omep) or lansoprazole (Lansop)[37]. The two proton pump inhibitors significantly enhanced the decrease in hematocrit when co-administered with naproxen (no decrease in hematocrit was observed in rats treated with a proton pump inhibitors alone).
- Citation: Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol 2013; 19(12): 1861-1876
- URL: https://www.wjgnet.com/1007-9327/full/v19/i12/1861.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i12.1861